Martina Hansens Hospital AS

The research at Martina Hansens Hospital AS concentrates on immune‑mediated disorders, testing innovative therapies and monitoring strategies to achieve sustained disease control.

• Evaluation of proactive therapeutic drug monitoring in rheumatoid arthritis
• Secukinumab combined with glucocorticoid taper in giant cell arteritis
• Comparative effectiveness of biologic versus conventional treatment approaches

By integrating advanced drug‑level assessments, the site aims to improve outcomes for patients with rheumatoid arthritis and giant cell arteritis across Norway.

Studies at the orthopedic department target joint and bone conditions, seeking therapies that reduce pain, limit disease progression, and potentially avoid surgery.

• Ultrasound‑guided injection therapy versus primary surgery for carpal tunnel syndrome
• Zoledronic acid as disease‑modifying agent in hip osteoarthritis
• Long‑term management strategies for osteoarthritis of the hip

The goal is to provide patients with safer, effective options for carpal tunnel syndrome and hip osteoarthritis, leveraging treatments such as zoledronic acid.

The site’s investigations include peripheral nerve disorders, focusing on minimally invasive interventions and functional recovery.

• Assessing outcomes of ultrasound‑guided injections for carpal tunnel syndrome
• Evaluating postoperative recovery protocols after nerve decompression
• Integrating imaging biomarkers to guide treatment of nerve compression

Through these efforts, Martina Hansens Hospital AS aims to enhance quality of life for individuals affected by carpal tunnel syndrome and related neuropathies.